Cargando…

Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, and Geographic Distribution

PURPOSE: In this study, we analyzed the clinical distribution and drug resistance of carbapenem-resistant Klebsiella pneumoniae (CRKP) strains, the minimum inhibitory concentrations (MIC), MIC50 and MIC90, and geographical distribution in Hebei Province, China. We aimed to provide epidemiological re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Na, Zhan, Minghua, Liu, Jianhua, Wang, Yao, Hou, Yongwang, Li, Caiqing, Li, Jia, Han, Xuying, Liu, Jinlu, Chen, Yong, Fan, Jingjing, Tang, Jianhua, Lu, Wenhua, Zhong, Xinran, Zhang, Zhihua, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881927/
https://www.ncbi.nlm.nih.gov/pubmed/35228807
http://dx.doi.org/10.2147/IDR.S347343
_version_ 1784659588907270144
author Wang, Na
Zhan, Minghua
Liu, Jianhua
Wang, Yao
Hou, Yongwang
Li, Caiqing
Li, Jia
Han, Xuying
Liu, Jinlu
Chen, Yong
Fan, Jingjing
Tang, Jianhua
Lu, Wenhua
Zhong, Xinran
Zhang, Zhihua
Zhang, Wei
author_facet Wang, Na
Zhan, Minghua
Liu, Jianhua
Wang, Yao
Hou, Yongwang
Li, Caiqing
Li, Jia
Han, Xuying
Liu, Jinlu
Chen, Yong
Fan, Jingjing
Tang, Jianhua
Lu, Wenhua
Zhong, Xinran
Zhang, Zhihua
Zhang, Wei
author_sort Wang, Na
collection PubMed
description PURPOSE: In this study, we analyzed the clinical distribution and drug resistance of carbapenem-resistant Klebsiella pneumoniae (CRKP) strains, the minimum inhibitory concentrations (MIC), MIC50 and MIC90, and geographical distribution in Hebei Province, China. We aimed to provide epidemiological research data, formulate appropriate combined treatment schemes, reasonably select antibiotics, and standardize nosocomial infection control schemes. PATIENTS AND METHODS: A total of 6328 strains of CRKP were collected from 2017 to 2019. The MIC was determined for the drug sensitivity test, and the experimental data were statistically analyzed using WHONET5.6. RESULTS: The detection rate of CRKP increased annually from 13.4% in 2017 to 14.5% in 2018, and 14.6% in 2019. The ratio of males to females was approximately 2:1; 53.6% were elderly, 39% were adults, 4.8% were minors, and 2.5% were newborns. The specimens collected were mainly sputum (70.9%). The resistance rate of CRKP to carbapenems and other β-lactam antibiotics was found to be increasing, with resistance rates generally greater than 90%. The resistance rate to aminoglycoside antibiotics decreased yearly to approximately 50%, and the resistance rate to quinolones remained unchanged at approximately 80%. From 2017 to 2019, the resistance rate of CRKP in Hebei Province to various antibiotics was high, and the resistance rate to β-lactam antibiotics increased each year. CONCLUSION: The situation of CRKP resistance is severe in Hebei Province, China. The resistance rate to most antibiotics is very high and shows an upward trend. Among them, the resistance rate to polymyxin is low; however, few resistant strains do exist. MIC50 and MIC90 are higher than their MICs. It mainly causes lung infection in elderly men. This study is helpful to improve the diagnosis, treatment, and prevention of CRKP infection in our province.
format Online
Article
Text
id pubmed-8881927
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-88819272022-02-27 Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, and Geographic Distribution Wang, Na Zhan, Minghua Liu, Jianhua Wang, Yao Hou, Yongwang Li, Caiqing Li, Jia Han, Xuying Liu, Jinlu Chen, Yong Fan, Jingjing Tang, Jianhua Lu, Wenhua Zhong, Xinran Zhang, Zhihua Zhang, Wei Infect Drug Resist Original Research PURPOSE: In this study, we analyzed the clinical distribution and drug resistance of carbapenem-resistant Klebsiella pneumoniae (CRKP) strains, the minimum inhibitory concentrations (MIC), MIC50 and MIC90, and geographical distribution in Hebei Province, China. We aimed to provide epidemiological research data, formulate appropriate combined treatment schemes, reasonably select antibiotics, and standardize nosocomial infection control schemes. PATIENTS AND METHODS: A total of 6328 strains of CRKP were collected from 2017 to 2019. The MIC was determined for the drug sensitivity test, and the experimental data were statistically analyzed using WHONET5.6. RESULTS: The detection rate of CRKP increased annually from 13.4% in 2017 to 14.5% in 2018, and 14.6% in 2019. The ratio of males to females was approximately 2:1; 53.6% were elderly, 39% were adults, 4.8% were minors, and 2.5% were newborns. The specimens collected were mainly sputum (70.9%). The resistance rate of CRKP to carbapenems and other β-lactam antibiotics was found to be increasing, with resistance rates generally greater than 90%. The resistance rate to aminoglycoside antibiotics decreased yearly to approximately 50%, and the resistance rate to quinolones remained unchanged at approximately 80%. From 2017 to 2019, the resistance rate of CRKP in Hebei Province to various antibiotics was high, and the resistance rate to β-lactam antibiotics increased each year. CONCLUSION: The situation of CRKP resistance is severe in Hebei Province, China. The resistance rate to most antibiotics is very high and shows an upward trend. Among them, the resistance rate to polymyxin is low; however, few resistant strains do exist. MIC50 and MIC90 are higher than their MICs. It mainly causes lung infection in elderly men. This study is helpful to improve the diagnosis, treatment, and prevention of CRKP infection in our province. Dove 2022-02-22 /pmc/articles/PMC8881927/ /pubmed/35228807 http://dx.doi.org/10.2147/IDR.S347343 Text en © 2022 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Na
Zhan, Minghua
Liu, Jianhua
Wang, Yao
Hou, Yongwang
Li, Caiqing
Li, Jia
Han, Xuying
Liu, Jinlu
Chen, Yong
Fan, Jingjing
Tang, Jianhua
Lu, Wenhua
Zhong, Xinran
Zhang, Zhihua
Zhang, Wei
Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, and Geographic Distribution
title Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, and Geographic Distribution
title_full Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, and Geographic Distribution
title_fullStr Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, and Geographic Distribution
title_full_unstemmed Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, and Geographic Distribution
title_short Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, and Geographic Distribution
title_sort prevalence of carbapenem-resistant klebsiella pneumoniae infection in a northern province in china: clinical characteristics, drug resistance, and geographic distribution
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881927/
https://www.ncbi.nlm.nih.gov/pubmed/35228807
http://dx.doi.org/10.2147/IDR.S347343
work_keys_str_mv AT wangna prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT zhanminghua prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT liujianhua prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT wangyao prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT houyongwang prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT licaiqing prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT lijia prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT hanxuying prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT liujinlu prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT chenyong prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT fanjingjing prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT tangjianhua prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT luwenhua prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT zhongxinran prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT zhangzhihua prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution
AT zhangwei prevalenceofcarbapenemresistantklebsiellapneumoniaeinfectioninanorthernprovinceinchinaclinicalcharacteristicsdrugresistanceandgeographicdistribution